|
|
|
Insider
Information: |
Mattsson Jan |
Relationship: |
Chief Scientific Officer |
City: |
Boston |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
0 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
0 |
|
|
Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Albireo Pharma Inc |
ALBO |
Chief Scientific Officer |
2023-03-02 |
0 |
2016-11-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
18 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ALBO |
Albireo Pharma Inc |
Chief Scientific Officer |
|
2020-09-08 |
4 |
AS |
$45.55 |
$455,500 |
D/D |
(10,000) |
24,214 |
0 |
- |
|
ALBO |
Albireo Pharma Inc |
Chief Scientific Officer |
|
2021-01-21 |
4 |
A |
$0.00 |
$0 |
D/D |
5,500 |
29,714 |
0 |
- |
|
ALBO |
Albireo Pharma Inc |
Chief Scientific Officer |
|
2021-03-01 |
4 |
OE |
$1.00 |
$39,330 |
D/D |
39,330 |
69,044 |
0 |
- |
|
ALBO |
Albireo Pharma Inc |
Chief Scientific Officer |
|
2021-03-01 |
4 |
S |
$37.45 |
$572,996 |
D/D |
(15,300) |
53,744 |
0 |
- |
|
ALBO |
Albireo Pharma Inc |
Chief Scientific Officer |
|
2021-03-02 |
4 |
S |
$36.07 |
$572,207 |
D/D |
(15,770) |
37,974 |
0 |
- |
|
ALBO |
Albireo Pharma Inc |
Chief Scientific Officer |
|
2021-03-03 |
4 |
S |
$36.20 |
$14,481 |
D/D |
(400) |
37,574 |
0 |
- |
|
ALBO |
Albireo Pharma Inc |
Chief Scientific Officer |
|
2022-01-18 |
4 |
A |
$0.00 |
$0 |
D/D |
21,600 |
59,174 |
0 |
- |
|
ALBO |
Albireo Pharma Inc |
Chief Scientific Officer |
|
2022-01-24 |
4 |
AS |
$24.88 |
$20,105 |
D/D |
(808) |
58,366 |
0 |
- |
|
ALBO |
Albireo Pharma Inc |
Chief Scientific Officer |
|
2022-04-22 |
4 |
AS |
$32.92 |
$6,585 |
D/D |
(200) |
58,166 |
0 |
- |
|
ALBO |
Albireo Pharma Inc |
Chief Scientific Officer |
|
2022-07-22 |
4 |
AS |
$24.68 |
$5,058 |
D/D |
(205) |
57,961 |
0 |
- |
|
ALBO |
Albireo Pharma Inc |
Chief Scientific Officer |
|
2022-10-24 |
4 |
AS |
$19.58 |
$3,954 |
D/D |
(202) |
57,759 |
0 |
- |
|
ALBO |
Albireo Pharma Inc |
Chief Scientific Officer |
|
2023-01-19 |
4 |
A |
$0.00 |
$0 |
D/D |
55,000 |
109,474 |
0 |
- |
|
ALBO |
Albireo Pharma Inc |
Chief Scientific Officer |
|
2023-01-19 |
4 |
AS |
$43.80 |
$135,254 |
D/D |
(3,088) |
54,671 |
0 |
- |
|
ALBO |
Albireo Pharma Inc |
Chief Scientific Officer |
|
2023-01-23 |
4 |
AS |
$43.80 |
$8,629 |
D/D |
(197) |
54,474 |
0 |
- |
|
ALBO |
Albireo Pharma Inc |
Chief Scientific Officer |
|
2023-03-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(35,524) |
0 |
0 |
- |
|
ALBO |
Albireo Pharma Inc |
Chief Operating Officer |
|
2016-11-03 |
4 |
A |
$0.00 |
$0 |
D/D |
59,214 |
59,214 |
0 |
- |
|
ALBO |
Albireo Pharma Inc |
Chief Operating Officer |
|
2018-06-12 |
4 |
AS |
$32.19 |
$585,060 |
D/D |
(18,097) |
41,117 |
0 |
- |
|
ALBO |
Albireo Pharma Inc |
Chief Operating Officer |
|
2018-06-13 |
4 |
AS |
$32.08 |
$221,448 |
D/D |
(6,903) |
34,214 |
0 |
- |
|
18 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|